Name: UMIN ID:
Unique ID issued by UMIN | UMIN000037105 |
---|---|
Receipt number | R000042224 |
Scientific Title | Integrated Three Japanese Institution's Experience of Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphoma Treated with Yittrium 90 Ibritumomab Tiuxetan (Zevalin): Factors Associated with Long-Term Responses |
Date of disclosure of the study information | 2019/06/19 |
Last modified on | 2023/06/22 09:37:19 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/06/19 09:34:47 | ||
2 | Update | 2021/12/28 11:09:04 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
3 | Update | 2023/06/22 09:37:19 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |